Compare Natera Inc. Common Stock (NTRA) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Western Digital Corp — how do they compare? Natera Inc. Common Stock trades at $394 (market cap $57.03B), while Western Digital Corp trades at $348.58 (market cap $142.51B). The key difference: Western Digital Corp is far larger — about 2.5× Natera Inc. Common Stock's market cap, and Western Digital Corp pays a 0.16% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Western Digital Corp for 38 Days on average.
| NTRA | WDC | |
|---|---|---|
Market Cap | $57.03B | $142.51B |
Volume | 1,131,157 | 12,354,354 |
Sector | Health | Technology |
52-Week High | $425.64 | $746.23 |
52-Week Low | $179.42 | $120.44 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $56.18B | $141.98B |
Dividend Yield | — | 0.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Western Digital (WDC) trades at $364.10, down 5.9% amid concerns over increased competition after Toshiba's plans to expand AI storage production. The stock shows strong fundamentals with recent earnings beats (Q4 2025-Q2 2026) and robust profitability (net margin 71.97%, ROE 131.02%). Technical indicators are mixed with bearish moving averages but oversold RSI signals. Analyst consensus remains strongly bullish with 72% buy ratings and $643 price target.
WDC presents a compelling value opportunity with attractive valuation multiples (P/E 14.14) and strong AI-driven growth prospects, though near-term pressure from competitive threats and market volatility requires careful monitoring. The company's leadership in high-capacity drives for AI infrastructure supports long-term upside potential despite recent selloff.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
